Outpatient Lung Impedance-Guided Preventive Therapy in Patients With Chronic Heart Failure (CHF)
- Conditions
- Chronic Congestive Heart Failure
- Interventions
- Other: Lung impedence-guided treatment
- Registration Number
- NCT01315223
- Lead Sponsor
- Hillel Yaffe Medical Center
- Brief Summary
Patients suffering from Chronic Heart Failure (CHF) are hospitalized for acute heart failure (AHF) several times a year. Currently, we have no method for prediction of future developments of AHF. In our center we have investigated the monitoring of lung impedence as a predictor for future deterioration. It was found that a decrease in lung impedence of more than 15% from normal value predicts AHF development with sensitivity of 98%. In this study we try to prove the hypothesis that preventive treatment according to lung impedence value may prevent future hospitalizations for AHF and improve clinical outcome.
Patients recruited by year:
2011 - 50; 2012 - 25; 2013 - 35; 2014 - 30; 2015 - 50; 2016 - 5
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 300
- Patients suffering from CHF, NYHA II-IV class
- LV lower than 35% to LV lower than 45%
- Patients with additional disease with life-expectancy of less than 2 years
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Lung impedence-guided treatment Lung impedence-guided treatment -
- Primary Outcome Measures
Name Time Method Reduction of hospitalization for acute heart failure Five years
- Secondary Outcome Measures
Name Time Method Improved clinical outcome for CHF patients Five years
Trial Locations
- Locations (1)
Hillel Yaffe Medical Center
🇮🇱Hadera, Israel